Market
Scenario:
HIV
prevalence in Africa, specifically in Southern region is very high as compared
to North African region. Approximately 1 out of 4 is suffering from HIV.
Southern and Eastern region of Africa has one of the highest prevalence rate of
HIV, about 19 million people have HIV. While HIV prevalence is low in North
Africa but the number of cases of HIV are increasing rapidly. There is no cure
for HIV but drugs manufacturing companies are investing huge money in R&D
to develop drugs for HIV. Over 3000 patients were died in sub Saharan Africa
due to HIV in 2015. Following 10 countries from Africa consists of 80% of total
HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United
Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.
Middle
East and Africa HIV
Diagnosis & Treatment Market is growing moderately. Middle
East and Africa HIV Diagnosis & Treatment Market is expected to grow at a
CAGR of 3.3% and expected to reach US$ 2.07 billion by 2023 from US$ 1.65
billion in 2016.
Intended
Audience
- Hospitals and Clinics
- HIV Diagnosis & Treatment
drugs manufacturers
- HIV Diagnosis & Treatment
drugs suppliers
- Government and Independent
Regulatory Authorities
- Research and Development
(R&D) Companies
- Market Research and Consulting Service
Providers
- Medical Research Laboratories
- Potential Investors
Key
Players for Middle East and Africa HIV Diagnosis & Treatment Market:
Some of
the key players in this market are: Abbott Laboratories (US), Boehringer
Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (US), Cipla Inc.
(India), F. Hoffmann-La Roche Ltd (Switzerland), Gilead (US), GlaxoSmithKline
plc. (UK), Johnson & Johnson Services, Inc.(US), ViiV Healthcare group of
companies (UK), Merck & Co., Inc. (US).
Segments:
Middle
East and Africa HIV Diagnosis & Treatment Market has been segmented on the
basis of diagnosis which comprise ELISA Test, Saliva Tests, Viral Load Test,
Western Blot, and Others. On the basis of treatment, market is segmented into
Protease inhibitors (PIs), Non-nucleoside reverse transcriptase inhibitors
(NNRTIs), Nucleoside or nucleotide reverse transcriptase inhibitors (NRTIs),
Entry or fusion inhibitors, Integrase inhibitors, and others.
Regional
Analysis of Middle East and Africa HIV Diagnosis & Treatment Market:
Considering
the scenario of the Middle East and African HIV Diagnosis & Treatment
market, Africa is believed to be the largest market for HIV Diagnosis &
Treatment. Moreover, the Rest of Middle East and Africa is growing and it is
the second largest market for Middle East and Africa HIV Diagnosis &
Treatment. On the other hand, UAE market is expected to grow at significant
rate in the Middle East and Africa HIV Diagnosis & Treatment during the
forecasted period. Saudi Arabia is likely to have a limited but moderate growth
in the market.
The
report for Middle East and Africa HIV Diagnosis & Treatment
Market of Market Research Future comprises extensive primary
research along with the detailed analysis of qualitative as well as
quantitative aspects by various industry experts, key opinion leaders to gain
the deeper insight of the market and industry performance. The report gives the
clear picture of current market scenario which includes historical and
projected market size in terms of value and volume, technological advancement,
macro economical and governing factors in the market. The report provides
detail information and strategies of the top key players in the industry. The
report also gives a broad study of the different markets segments and regions.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2990
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2990
Detailed
Table of Contents:
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
List Of Tables
Table 1 Middle East And Africa Hiv Diagnosis & Treatment
Market By Diagnosis
Table 2 Middle East And Africa Hiv Diagnosis & Treatment
Market By Treatment
Table 3 Middle East And Africa Hiv Diagnosis & Treatment
Market By Region
List Of Figures
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 Middle East And Africa Hiv Diagnosis & Treatment
Market By Diagnosis
Figure 4 Middle East And Africa Hiv Diagnosis & Treatment
Market By Treatment
Figure 5 Middle East And Africa Hiv Diagnosis & Treatment
Market By Region
Figure 6 Middle East And Africa Hiv Diagnosis & Treatment
Market By Region: Company Share Analysis, 2015 (%)
...Continued
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
